Sitosterolemia can impact cancer treatment in several ways. Patients with this condition may have altered lipid metabolism, which could influence the pharmacokinetics of lipid-soluble chemotherapy drugs. Additionally, the presence of xanthomas and other cardiovascular complications might necessitate modifications to the treatment regimen to ensure patient safety.
